155 related articles for article (PubMed ID: 36844783)
21. Application of a novel FAM-conjugated activity-based probe to determine cathepsin G activity intracellularly.
Schroeder R; Grzywa R; Wirtz CR; Sienczyk M; Burster T
Anal Biochem; 2020 Jan; 588():113488. PubMed ID: 31654611
[TBL] [Abstract][Full Text] [Related]
22. Cell surface cathepsin G can be used as an additional marker to distinguish T cell subsets.
Penczek A; Burster T
Biomed Rep; 2019 Apr; 10(4):245-249. PubMed ID: 30972220
[TBL] [Abstract][Full Text] [Related]
23. Elastolysis by proteinase 3 and its inhibition by alpha(1)-proteinase inhibitor: a mechanism for the incomplete inhibition of ongoing elastolysis.
Ying QL; Simon SR
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):356-61. PubMed ID: 11867344
[TBL] [Abstract][Full Text] [Related]
24. Sulfonated Nonsaccharide Heparin Mimetics Are Potent and Noncompetitive Inhibitors of Human Neutrophil Elastase.
Al-Horani RA; Aliter KF; Kar S; Mottamal M
ACS Omega; 2021 May; 6(19):12699-12710. PubMed ID: 34056422
[TBL] [Abstract][Full Text] [Related]
25. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin G activity lowers plasma LDL and reduces atherosclerosis.
Wang J; Sjöberg S; Tang TT; Oörni K; Wu W; Liu C; Secco B; Tia V; Sukhova GK; Fernandes C; Lesner A; Kovanen PT; Libby P; Cheng X; Shi GP
Biochim Biophys Acta; 2014 Nov; 1842(11):2174-83. PubMed ID: 25092171
[TBL] [Abstract][Full Text] [Related]
27. DNA structures decorated with cathepsin G/secretory leukocyte proteinase inhibitor stimulate IFNI production by plasmacytoid dendritic cells.
Skrzeczynska-Moncznik J; Wlodarczyk A; Banas M; Kwitniewski M; Zabieglo K; Kapinska-Mrowiecka M; Dubin A; Cichy J
Am J Clin Exp Immunol; 2013; 2(2):186-94. PubMed ID: 23885335
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation.
Burgener SS; Leborgne NGF; Snipas SJ; Salvesen GS; Bird PI; Benarafa C
Cell Rep; 2019 Jun; 27(12):3646-3656.e5. PubMed ID: 31216481
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Human Cytomegalovirus Entry into Host Cells Through a Pleiotropic Small Molecule.
Elste J; Kaltenbach D; Patel VR; Nguyen MT; Sharthiya H; Tandon R; Mehta SK; Volin MV; Fornaro M; Tiwari V; Desai UR
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121406
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D supplementation induces CatG-mediated CD4
Lai X; Liu X; Cai X; Zou F
Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin.
Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W
Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes.
Burster T; Beck A; Tolosa E; Marin-Esteban V; Rötzschke O; Falk K; Lautwein A; Reich M; Brandenburg J; Schwarz G; Wiendl H; Melms A; Lehmann R; Stevanovic S; Kalbacher H; Driessen C
J Immunol; 2004 May; 172(9):5495-503. PubMed ID: 15100291
[TBL] [Abstract][Full Text] [Related]
33. Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.
Al-Horani RA; Karuturi R; Lee M; Afosah DK; Desai UR
PLoS One; 2016; 11(7):e0160189. PubMed ID: 27467511
[TBL] [Abstract][Full Text] [Related]
34. Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. Determination of the kinetic mechanism of inhibition and localization of cathepsin G binding to the thrombospondin 1 type 3 repeats.
Hogg PJ; Owensby DA; Chesterman CN
J Biol Chem; 1993 Oct; 268(29):21811-8. PubMed ID: 8408036
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin G is differentially expressed in primary human antigen-presenting cells.
Stoeckle C; Sommandas V; Adamopoulou E; Belisle K; Schiekofer S; Melms A; Weber E; Driessen C; Boehm BO; Tolosa E; Burster T
Cell Immunol; 2009; 255(1-2):41-5. PubMed ID: 19036358
[TBL] [Abstract][Full Text] [Related]
36. Plasmin regulation through allosteric, sulfated, small molecules.
Al-Horani RA; Karuturi R; White DT; Desai UR
Molecules; 2015 Jan; 20(1):608-24. PubMed ID: 25569517
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of cathepsin G: a patent review (2005 to present).
Kosikowska P; Lesner A
Expert Opin Ther Pat; 2013 Dec; 23(12):1611-24. PubMed ID: 24079661
[TBL] [Abstract][Full Text] [Related]
38. Lignosulfonic Acid Sodium Is a Noncompetitive Inhibitor of Human Factor XIa.
Kar S; Bankston P; Afosah DK; Al-Horani RA
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577586
[TBL] [Abstract][Full Text] [Related]
39. Surface plasmon resonance imaging biosensor for cathepsin G based on a potent inhibitor: development and applications.
Gorodkiewicz E; Sieńczyk M; Regulska E; Grzywa R; Pietrusewicz E; Lesner A; Lukaszewski Z
Anal Biochem; 2012 Apr; 423(2):218-23. PubMed ID: 22369897
[TBL] [Abstract][Full Text] [Related]
40. Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G.
Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
Biochem Pharmacol; 2006 Jan; 71(3):287-93. PubMed ID: 16310171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
